Results 61 to 70 of about 11,884 (322)

Using the post‐operative quality recovery scale to evaluate recovery with different neuromuscular blocking reversal agentsin the Portuguese population ‐ interim analysis results: 1AP3‐8 [PDF]

, 2013
Background and Goal of Study: Post-operative Quality Recovery Scale (PQRS), is the first scale evaluating several domains of postoperative recovery. The objectives of this study were to compare overal and physiologic, cognitive, and functional domains
Amorim, P., Bismarck, A., Gomes, B., Lagarto, F., Nogueira, M., Rodrigues, N.   +5 more
core   +1 more source

Suspected Sugammadex Hypersensitivity following Repeated Administration in the Setting of Multiple Flap Takebacks in a Brief Timespan

Case Reports in Anesthesiology, 2021
Sugammadex hypersensitivity is an uncommon event that typically occurs at higher doses. We report a case of suspected sugammadex hypersensitivity in a patient who developed hypoxia and bronchospasm following three administrations of the standard 2 mg/kg ...
Elizabeth G. Zolper, Alan H. Kim, Kevin G. Kim, Paige K. Dekker, Jenna C. Bekeny, David H. Song, Kenneth L. Fan   +6 more
doaj   +1 more source

Anafilaxia por sugammadex en paciente pediátrico

Revista Alergia México, 2021
Introducción: Sugammadex es una ciclodextrina que revierte el bloqueo neuromuscular, especialmente de rocuronio. La incidencia de anafilaxia producida por su uso es de 1:1.000 y 1:20.000, se observa principalmente en sujetos de origen asiático ...
Juana Bautista Joyanes-Romo, Ana Isabel Navarro-Abad, José Miguel Urra-Ardanaz, Óscar González-Jiménez, Alberto Palacios, Jaime Vinicio Meneses-Sotomayor, Marta Pascual, Ma. de Gracia Villanueva, Davinia Garrido, Ana Joyanes, Pedro Ángel Galindo-Bonilla   +10 more
doaj   +1 more source

Impact of Sugammadex Versus Neostigmine Reversal on Postoperative Recovery Time in Patients With Obstructive Sleep Apnea Undergoing Bariatric Surgery: A Double-Blind, Randomized Controlled Trial

Anesthesia and Analgesia
BACKGROUND: Residual neuromuscular blockade can be associated with serious postoperative complications. Sugammadex is a newer neuromuscular blocking drug (NMBD) reversal agent that rapidly and completely reverses rocuronium.
Olawale Ajetunmobi, David Wong, A. Perlas, Wesley Rajaleelan, Stella Wang, E. Huszti, Timothy Jackson, Frances Chung, Jean Wong   +8 more
semanticscholar   +1 more source

In vivo animal studies with sugammadex [PDF]

Anaesthesia, 2009
SummaryA review is presented of animal studies of the selective steroidal neuromuscular blocking drug binding agent sugammadex. These studies demonstrate that sugammadex is faster in onset than the currently used acetylcholinesterase inhibitors, has no muscarinic effects, and is characterised by lack of adverse effects on other organs.
Booij, L.H.D.J., Egmond, J. van, Driessen, J.J., Boer, H.D. de   +3 more
openaire   +3 more sources

Discordance between Train-of-Four Response and Clinical Symptoms in a Patient with Amyotrophic Lateral Sclerosis [PDF]

, 2014
A 47-year-old woman with amyotrophic lateral sclerosis was scheduled for total thyroidectomy with cervical node dissection. During anesthetic management by total intravenous anesthesia using remifentanil, propofol, and rocuronium, train-of-four (TOF ...
Wol Seon Jung,, Woon Rak Son,, Youn Yi Jo,, Young Jin Chang,   +3 more
core   +1 more source

Knowledge and Understanding of the Safety and Efficacy Aspects of BRIDION® Among Canadian Anesthesiologists

Drugs - Real World Outcomes, 2020
Background BRIDION® (sugammadex sodium) is an agent for the reversal of neuromuscular blockade (NMB) induced by rocuronium and vecuronium in general anesthesia.
Annette Stemhagen, Parambir Bhangu, Wenjun Zhong, Michele Julian, Gretty Deutsch, Carol Koro   +5 more
doaj   +1 more source

Required dose of sugammadex or neostigmine for reversal of vecuronium‐induced shallow residual neuromuscular block at a train‐of‐four ratio of 0.3

Clinical and Translational Science, 2022
Residual shallow neuromuscular block (NMB) is potentially harmful and contributes to critical respiratory events. Evidence for the optimal dose of sugammadex required to reverse vecuronium‐induced shallow NMB is scarce. The aims of the present study were
Jing He, Huan He, Xing Li, Mei Sun, Zhihao Lai, Bo Xu   +5 more
doaj   +1 more source

Cardiac Arrest in the Post-anesthesia Care Unit (PACU): Postoperative Recurrence of Neuromuscular Block After Sugammadex Reversal

Cureus
Sugammadex has transformed clinical practice by enabling the rapid reversal of rocuronium-induced neuromuscular block (NMB) at any depth. We present a case of cardiac arrest following postoperative recurarization despite the sugammadex-induced transient ...
Vasyl Katerenchuk, Alexandre Calçada, Raquel Louzada, Daniela Rosinha, A. C. Batista, Andreia Capelão, L. Cordeiro   +6 more
semanticscholar   +1 more source

Sugammadex compared with Neostigmine/Glycopyrrolate: An Analysis of Total PACU Time, Responsiveness, and Potential for Economic Impact

INNOVATIONS in Pharmacy, 2019
Studies have previously shown sugammadex works faster and more effectively than neostigmine/glycopyrrolate at reversal of neuromuscular blockade by rocuronium and vecuronium.
Yoon Jung Lee, Kayla Leigh Money, Amber Elliott   +2 more
doaj   +1 more source